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Objective: Experience with treatment and outcome of superficial adenocarcinoma
of the esophagus is limited. The purpose of this study was to evaluate the results of
surgical management and identify predictors of survival.
Methods: Between September 1985 and December 1999, 122 patients underwent
resection. Eighty-nine percent were men (mean age 63 ± 10 years; range 35-83
years). Sixty (49%) patients were in endoscopic surveillance programs and 48
(39%) had the preoperative diagnosis of high-grade dysplasia. Forced expiratory
volume in 1 second was less than 2 L in 12 (12%). Seventy-five (61%) patients
underwent transhiatal esophagectomy. Pathologic stage was N1 in 8 (7%).
Pulmonary complications necessitating reintubation (respiratory failure) occurred
in 10 (8%) patients. Time-related survival models were developed for decision-
making (preoperative), prognosis (operative), and hospital care (postoperative).
Results: Operative mortality was 2.5%. Survival at 1, 5, and 10 years was 89%,
77%, and 68%. Preoperative decision-making factors associated with ideal outcome
were 1-second forced expiratory volume of more than 2 L, surveillance, preopera-
tive diagnosis of high-grade dysplasia, and planned transhiatal esophagectomy.
Prognosis was decreased in younger patients and in those with N1 disease.
Postoperative respiratory failure increased mortality.
Conclusions: Surgery is the treatment of choice for superficial adenocarcinoma of
the esophagus. The ideal patient has a preoperative diagnosis of high-grade dyspla-
sia found at surveillance, good pulmonary function, and undergoes a transhiatal
esophagectomy. Discovery of N1 disease or development of postoperative respira-
tory failure reduces the benefits of surgery. 
In the Western world, adenocarcinoma of the esophagus has one of the mostrapidly increasing incidences of all carcinomas.1,2 Preferentially it afflictsmiddle-aged and elderly white men. Many have long-standing reflux andusually an associated Barrett esophagus.3 Awareness of the cancer potentialin this population and emergence of endoscopic Barrett surveillance haveimproved detection of superficial adenocarcinoma.
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Superficial esophageal cancers do not invade deeper than
the submucosa (Figure 1). Data concerning the treatment of
these carcinomas are limited and obsolete. Extrapolation of
results of surgery for advanced-stage esophageal cancer is
not useful and ignores the special characteristics of this
group of patients. Therefore, it is important to establish cur-
rent surgical standards for the treatment of superficial ade-
nocarcinoma of the esophagus.
The purposes of this study were to (1) evaluate the results
of surgical management of superficial adenocarcinoma of
the esophagus and (2) identify predictors of long-term sur-
vival for (a) decision-making (preoperative factors), (b)
prognostication (operative factors), and (c) hospital care
(postoperative complications).
Patients and Methods
Patients
From our prospective surgical database of 577 patients under-
going resection of esophageal carcinoma at The Cleveland Clinic
Foundation beginning in January 1983, 122 patients were found to
have superficial adenocarcinoma of the esophagus. Patients were
not candidates if they received induction therapy for more
advanced cancers that resulted in downstaging to high-grade dys-
plasia or T1 adenocarcinoma. The first patient presented in
September 1985; patients were identified through the end of cal-
endar year 1999. Patient ages ranged from 35 to 83 years (mean 63
± 10 years). All were white, and 108 (89%) were men. The num-
ber of patients operated on increased across time (Appendix I and
Figure 2). Preoperative pulmonary function is displayed in Table 1.
Sixty (49%) patients were in endoscopic surveillance programs
(Appendix I). Eighty-nine (73%) patients had long-segment (>3
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Figure 1. Superficial adenocarcinoma of the esophagus: depth of tumor invasion. The left-hand portion of the
picture is an expanded view of a cross-section of the esophagus (lower right). HGD, High-grade dysplasia,
which is intraepithelial carcinoma without invasion of the basement membrane; T1a, T1 intramucosal invasion
of the lamina propria or muscularis mucosa, but not beyond; and T1b, T1-submucosal carcinoma with invasion
limited to the submucosa.
TABLE 1. Preoperative pulmonary function
Measure n Mean ± SD Range
FVC (L) 96 4.0 ± 1.0 1.7-6.0
% FVC 93 95 ± 17 47-138
FEV1 (L) 98 2.9 ± 0.8 0.9-5.0
% FEV1 95 87 ± 18 44-130
FVC, Forced vital capacity; % FVC, percent of predicted FVC based on
height, sex, and age; FEV1, 1-second forced expiratory volume; % FEV1,
percent predicted.
TABLE 2. Tumor pathology
Characteristic No. % of 122
T
High-grade dysplasia 38 31
T1a 53 43
T1b 31 25
N
N0 114 93
N1 8 7
Stage
0 38 31
I 76 62
T1a N0 51 42
T1b N0 25 20
IIB 8 7
T1a N1 2 2
T1b N1 6 5
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cm) Barrett esophagus. Preoperative tissue diagnosis was high-
grade dysplasia in 48 (39%) patients and invasive adenocarcinoma
in 74 (61%).
Surgical Approach
Transhiatal esophagectomy was done in 75 (61%) patients, thora-
cotomy with an abdominal incision in 46 (38%), and laparotomy
in 1 (1%). Anastomosis was constructed in the neck in 101 (83%)
patients and in the chest in 21 (17%). Guided by endoscopy and
endoscopic ultrasound, the surgical technique evolved from rou-
tine thoracotomy to transhiatal esophagectomy with lymph node
sampling for those patients with a low risk of lymph node metas-
tases (high-grade dysplasia or T1a intramucosal cancers),4 as illus-
trated by Appendix Figure I, A and B and Appendix I. Those
patients in whom deeper invasion was preoperatively diagnosed
underwent thoracotomy and lymphadenectomy.
Tumor Pathology 
The following definitions for depth of tumor invasion were used:
high-grade dysplasia, intraepithelial carcinoma without invasion
of the basement membrane; T1—intramucosal (T1a), invasion of
the lamina propria or muscularis mucosa, but not beyond; and T1—
submucosal (T1b), carcinoma with invasion limited to the submu-
cosa (Figure 1, Table 2). In 48 patients with a preoperative diag-
nosis of high-grade dysplasia, the esophagectomy specimens
revealed high-grade dysplasia in 29 (60%), T1a N0 in 14 (29%),
T1b N0 in 4 (8%), and T1b N1 in 1 (2%) patient. In 74 patients
with a preoperative diagnosis of invasive carcinoma, the
esophagectomy specimens revealed high-grade dysplasia in 9
(12%), T1a N0 in 37 (50%), T1a N1 in 2 (3%), T1b N0 in 21
(28%), and T1b N1 in 5 (7%) patients.
Outcomes
Postoperative complications were recorded and assessed. The lat-
ter included respiratory failure (defined as need for reintubation),
aspiration, vocal cord paralysis, anastomotic leak, and wound
infection (defined as infections not associated with an anastomot-
ic leak). These complications were reviewed in detail at the time of
data analyses.
Patients were followed up by periodic clinic visits; however,
cross-sectional systematic follow-up was made in January 2000.
Mean follow-up of all patients was 47 ± 41 months (median 38
months), with follow-up of survivors being 50 ± 41 months.
Cancer recurrence, time of diagnosis, and site were recorded. A
mode of death was ascertained from clinical records and reports
from the families.
Data Analyses
Descriptive. Descriptive statistics are summarized as the mean and
standard deviation for continuous variables and as frequencies and
percentages for categorical variables. Nonparametric estimates of
survival were obtained by the method of Kaplan and Meier.5 The
parametric method was used to resolve the number of phases of
instantaneous risk of death (hazard function) and to estimate their
shaping parameters.6*
Multivariable analysis
STRATEGY. The strategy for the multivariable analysis used a
sequential approach to variables that reflects the purposes of the
study.
DECISION-MAKING. Preoperative variables and those reflecting the
operative strategy (transhiatal vs thoracotomy approach, construc-
tion of the anastomosis in the neck or chest), which would be
determined preoperatively, were examined. This was labeled the
decision model.
PROGNOSTICATION. Tumor pathologic variables were added to the
preoperative candidate variables to refine patient prognosis. The
preoperative diagnostic variables were not retained in this analysis.
This was labeled the prognostic model.
HOSPITAL CARE. In addition to the aforementioned variables, the
influence of postoperative complications was examined, recogniz-
ing that these followed “time zero” but preceded the dominant late
hazard phase. This was labeled the hospital care model. To sup-
plement this latter model, multivariable logistic regression was
The Journal of Thoracic and Cardiovascular Surgery • Volume 122, Number 6   1079
Figure 2. Accrual of cases by year of operation.
*Available by anonymous ftp from ftp://uabcvsr.cvsr.uab.edu.
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also used on the complications themselves to identify factors pre-
disposing patients to their occurrence.
Because the surgical technique and decision-making changed
across time (Appendix I) and simultaneously early mortality
improved (P = .01), we analyzed the potentially confounding
trends across time to identify if possible those changes that
improved results. The multivariable analyses presented all account
adequately for the information attributable to the date of operation.
These models include factors whose prevalence changed across
time. Strategically, we believe that such models are desirable and
more helpful than simply attributing the improvement in results to
a so-called learning curve.
VARIABLE SCREENING. Initial screening of variables possibly relat-
ed to survival used the log-rank test and the Cox proportional haz-
ards model. The potential risk factors (variables) were organized for
analysis as in Tables 1 to 3. Continuous and ordinal variables were
assessed univariably by decile risk analysis to suggest transforma-
tions of scale to incorporate into the multivariable analyses to ensure
that the relation of these variables to outcome was well calibrated
with respect to model assumptions. Informative imputation for miss-
ing values of pulmonary function tests used a multiple regression
model based on available function tests, age, and sex. 
VARIABLE SELECTION. For each of the 3 hazard models, multi-
variable survival analysis was performed for each hazard phase
using a directed technique of entry of variables into the multivari-
able models.7 However, the early hazard phase, determined from
the data, was calculated to contain only 5 events; thus, there was
limited ability to identify early-phase risk factors.
A P = .1 criterion for retention of variables in the final models
was used. Because of small study size, bootstrap resampling was
used to validate the models.8 Further details of this method are
supplied in Appendix II. Thus, the risk factors were not only
identified as statistically significant by traditional analysis, but
also occurred the most frequently in bootstrap analysis. The
tables of risk factors include frequency of occurrence from mul-
tivariable bootstrap modeling, as well as conventional magnitude
and certainty of the association.
Presentation. Because fewer than 10 percent of the patients
were followed up longer than 10 years, all graphic presentations
are truncated at 10 years.
Confidence limits (CL) of proportions are also equivalent to 1
standard error (68% CL).
Tables of risk factors identified in the hazard domain are pre-
sented with their regression coefficients rather than hazard ratio,
because the model is not one of proportional hazards. Instead,
because the hazard function multivariable analyses are completely
parametric (generate an equation), “nomograms” from the analy-
ses are presented in which specific values are entered into the
equations, the equations solved, and the results presented graphi-
cally with confidence limits.
Results
Evaluation of Surgical Results
There were 3 operative deaths. Two patients died in the hos-
pital after the operation and 1 within 30 days, for an opera-
tive mortality of 2.5% (CL 1.1%-4.9%). Three additional
deaths, 2 from respiratory complications and 1 from gas-
trointestinal bleeding, occurred in the first 6 months.
Important postoperative morbidity included wound
infections not associated with anastomotic leak in 18
(15%) patients, anastomotic leak in 16 (13%) patients,
respiratory failure requiring reintubation in 10 (8%)
patients, vocal cord paralysis in 8 (7%) patients, and clin-
ically important aspiration in 6 (5%) patients. The occur-
rence of wound infections was consistent across time (P =
.4). Anastomotic leaks occurred similarly when the anas-
tomosis was constructed in the chest (4/21 patients, 19%)
or in the neck (12/101 patients, 12%), P = .4. The occur-
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Figure 3. Survival stratified according to patients not experiencing postoperative respiratory failure (open circles)
compared with patients experiencing respiratory failure (open squares). The number of patients at risk at various
time points is given along with confidence limits equivalent to 1 standard deviation (see “Patients and Methods”).
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rence of respiratory failure requiring reintubation dramat-
ically fell during the 1980s (Appendix I, Appendix Figure
I, C); thus, it occurred more often after thoracotomy (8/46
patients, 17%) than after a transhiatal approach (2/75
patients, 3%), P = .006. Survival was importantly dimin-
ished in patients experiencing the complication of respi-
ratory failure (Figure 3). With increasing experience,
there was a general decline in the occurrence of any com-
plication (P = .03) and particularly of those other than
wound infections (P = .008, Appendix Figure I, D).
Overall survival, including operative deaths, was 89%,
77%, and 68% at 1, 5, and 10 years after the operation
(Figure 4, A). The instantaneous risk of death was high
immediately after the operation, then fell to a constant level
of 4.2% per year (CL 3.3%-5.4%) by about 6 months post-
operatively (Figure 4, B).
Thirteen patients died of cancer. Three died with locore-
gional recurrence and 10 with distant metastases. There
were 6 noncancer deaths.
Predictors of Survival
Variables individually associated (univariable) with time-
related, all-cause mortality included older age, lower values
of pulmonary function tests, lack of endoscopic surveillance,
increasing depth of tumor invasion, regional lymph node
metastasis, and operation earlier in the experience (Table 3).
Decision model. Low forced expiratory volume in 1 sec-
ond (FEV1), unindexed to sex, age, and size, was a risk fac-
tor for early death (Table 4). Risk became evidently differ-
ent (defined as non-overlapping confidence limits compared
with the normal value) only for FEV1 values under about 2
L (Figure 5).
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Figure 4. Survival after operation. Nonparametric Kaplan-Meier time-related estimates are presented as open cir-
cles accompanied by asymmetric confidence limits equivalent to 1 standard error. The smooth solid curve is the
completely independent parametric estimate of the distribution of intervals to death. These are accompanied by
confidence limits equivalent to 1 standard error. The numbers in parentheses represent the number of patients
being followed up at that point in time. A, Survival. B, Hazard function.
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Late survival was best for patients in an endoscopic sur-
veillance program, those with high-grade dysplasia rather
than invasive adenocarcinoma on preoperative biopsy, and
for patients who underwent a transhiatal esophagectomy
(Table 4). These variables are reasonably secure because
their frequency of occurrence by bootstrap resampling
was greater than 50% except for preoperative tumor diag-
nosis. Figure 6 represents 2 solutions, the best and the
worst, of the decision model (“nomogram,” see “Patients
and Methods”).
Prognostic model. The addition of pathologic stage to
the decision-model variables refined the patients’ prog-
noses. N1 disease was the most powerful predictor of long-
term prognosis (Table 5). Although depth of tumor inva-
sion (T) was univariably related to prognosis (Figure 7), its
importance was overwhelmed in the analysis by the pres-
ence of N1 disease (Figure 8). The accuracy of this model
is corroborated by the comparison to actual deaths; from
the parametric model, we predict 5.6 deaths among the
patients with high-grade dysplasia versus 4 actual (P = .5),
9.3 deaths among T1a patients versus 9 actual (P = .9), and
10.1 deaths among T1b patients versus 12 actual (P = .5)
(Appendix Figure III).
After accounting for pathologic stage, age at operation
became a risk factor. No sharp age cutoff was identified: the
older the patient, the shorter the survival. However, patients
younger than 55 years had poorer survival than their US
population counterparts, whereas patients aged 55 to 75 and
General Thoracic Surgery Rice et al
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TABLE 3. Univariable Cox models
Variable Hazard ratio 95% CL P value
Demographic
Sex
Male/female 0.94 0.22-4.1 .9
Age at operation
Per 10-year increase 1.90 1.19-3.0 .007
History and preoperative findings
Barrett surveillance
Yes/no 0.28 0.11-0.70 .007
Barrett length
>3 cm/0-3 cm 0.53 0.24-1.21 .13
Preoperative diagnosis
T1 vs high-grade dysplasia 2.6 1.01-6.5 .05
Pulmonary function
FEV1
Per liter increase 0.19 0.08-0.45 <.001
< 2L/> 2L 7.6 2.3-24 <.001
Pathology
T stage
T1a vs high-grade dysplagia 1.96 0.60-6.4 .3
T1b vs high-grade dysplagia 4.6 1.48-14.3 .008
N stage
N1/N0 6.4 2.3-17.6 <.001
Year of operation
Per 1-year increase 0.87 0.78-0.97 .02
Hospital complications
Wound infection
Yes/no 1.02 0.34-3.0 .97
Anastomotic leak
Yes/no 1.09 0.37-3.2 .9
Respiratory failure
Yes/no 4.1 1.59-10.5 .004
Vocal cord paralysis
Yes/no 0.51 0.07-3.8 .5
Aspiration
Yes/no 2.1 0.62-7.2 .2
CL, Confidence limits.
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those more than 75 years lived about as long as expected
(Appendix Figure IV).
Hospital care model. The addition of postoperative com-
plications identified respiratory failure as a predictor of
early mortality (Table 6, Figure 3).
Discussion
Once rare, superficial adenocarcinoma of the esophagus is
being seen more often in clinical practice. The changing epi-
demiology of esophageal carcinoma, partly due to the increas-
ing incidence of Barrett esophagus in middle-aged and elder-
ly white men, accounts for this. Superficial adenocarcinoma of
the esophagus does not invade deeper than the submucosa. A
controversy is the inclusion of high-grade dysplasia in this
entity. High-grade dysplasia has cytologically malignant cells
that have not breached the basement membrane and invaded
the lamina propria. Presently, it is impossible to predict which
cases of high-grade dysplasia will progress, and at what rate,
to invasive cancer. Further, preoperative biopsy is unable to
define this group reliably. In our experience, 40% of patients
with a diagnosis of high-grade dysplasia have invasive cancer.
Therefore, because of the difficulty in its diagnosis and defin-
ition, we have included high-grade dysplasia in this report.
Superficial adenocarcinoma of the esophagus is a poten-
tially curable cancer. Patients with the earliest-stage can-
cers, high-grade dysplasia, or invasion of the mucosa (T1a)
and without regional lymph node metastases (N1) have the
best outcome. Patients in endoscopic surveillance programs
are those most likely to exhibit favorable pathologic find-
ings. However, patients not in surveillance programs and
those who have invasive cancer on preoperative biopsy still
may benefit from surgery.
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TABLE 4. Risk factors for death: decision model
Variable Coefficients ± SD P value Frequency*
Early postoperative hazard phase
Low FEV1 –1.01 ± 0.38† .008 93%
Late hazard phase
Not in surveillance program 1.40 ± 0.57 .01 72%
Invasive adenocarcinoma‡ 1.43 ± 0.64 .03 35%
Intended surgical approach: thoracotomy 1.34 ± 0.57 .02 64%
FEV1, One-second forced expiratory volume; SD, standard deviation.
*Frequency of appearance in 1000 bootstrap analyses (see “Patients and Methods”).
†[FEV1]
2 squared transform.
‡Preoperative diagnosis.
Figure 5. Ten-year survival according to FEV1 in 2 patients. One patient has high-grade dysplasia (HGD) on preop-
erative biopsy and the other invasive adenocarcinoma (Adeno). Both patients are in a Barrett surveillance pro-
gram, and both would have a planned transhiatal esophagectomy. The depiction represents 2 solutions of the
decision model (Table 4). Note the evident differences (nonoverlapping lower and upper confidence limits) below
FEV1s of approximately 2 L.
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The decision for surgery needs to include careful pulmonary
assessment. An absolute FEV1 of more than 2 L predicts
improved outcome. If thoracotomy is avoided and a transhiatal
approach is used, long-term survival is better for all patients
with superficial adenocarcinoma of the esophagus.
The surgical extreme is thoracotomy with 3-field lym-
phadenectomy.9 However, this puts the majority of patients at
risk of increased morbidity and mortality with questionable
gain.10 Lymphadenectomy and its extent are controversial,
especially in superficial cancers; by avoiding thoracotomy
through the use of transhiatal esophagectomy and substituting
lymph node sampling for lymphadenectomy, our study
demonstrates a survival advantage. The finding of regional
lymph node metastasis (N1) at operation is ominous and the
most powerful determinant of prognosis. The lymphatic
anatomy, which is peculiar to the esophagus, links depth of
tumor invasion to regional lymph node status (Figure 1).
Although considered independent factors in staging,11 T and
N are interrelated.4 In superficial adenocarcinoma of the
esophagus, as in advanced-stage cancer, the presence of N1
disease overwhelms depth of tumor invasion (T) in progno-
sis.12 The effect of age is paradoxic. Although increased age
is associated with decreased survival, the long-term benefit of
this operation is greatest to the elderly. Compared with equiv-
alent-aged cohorts, younger patients do worse. Therefore,
older patients should not be denied surgery.
General Thoracic Surgery Rice et al
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Figure 6. Ten-year predicted survival in a low- and high-risk patient. The low-risk patient has an average FEV1 of
3 L, is in a Barrett surveillance program, and has high-grade dysplasia on biopsy; a transhiatal approach is
planned. The high-risk patient has an FEV1 of 175 L, is not in a Barrett surveillance program, and has invasive ade-
nocarcinoma on biopsy; a thoracotomy is planned.
Figure 7. Survival stratified according to depth of tumor invasion (T). HGD, High-grade dysplasia.
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Careful preoperative selection and meticulous operative
management do not guarantee excellent outcome and may
be thwarted by postoperative complications. Improved hos-
pital care, which includes aggressive pulmonary hygiene,
prevention of aspiration, treatment of vocal cord neuraprax-
ia, and avoidance of early feeding, likely accounts for the
decrease in respiratory complications in this group as expe-
rience accumulated.
Recently, alternative therapies for superficial adenocarci-
noma of the esophagus have been proposed. They are
mucosal ablation and endoscopic mucosal resection.
Ablation eliminates pathologic review of the mucosa and
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Figure 8. Survival stratified according to the presence (N1) or absence (N0) of positive lymph nodes.
TABLE 5. Risk factors for death: prognostic model
Variable Coefficients ± SD P value Frequency*
Early postoperative hazard phase
Low FEV1 –1.05 ± 0.41† .01 86%
Late hazard phase
Old age 0.76 ± 0.32 .02 53%
Not in surveillance program 1.38 ± 0.58 .02 69%
N1 disease 2.2 ± 0.55 <.0001 66%
Thoracotomy 1.33 ± 0.58 .02 72%
FEV1, One-second forced expiratory volume; SD, standard deviation.
*Frequency of appearance in 1000 bootstrap analyses (see “Patients and Methods”).
†[FEV1]
2 squared transform.
TABLE 6. Risk factors for death: hospital care model
Variable Coefficients ± SD P value Frequency*
Early postoperative hazard phase
Low FEV1 –0.83 ± 0.42† .05 80%
Late hazard phase
Old age 1.03 ± 0.35 .004 53%
Not in surveillance program 1.91 ± 0.62 .002 64%
N1 disease 2.7 ± 0.58 <.0001 65%
Thoracotomy 1.18 ± 0.60 .05 71%
Postoperative respiratory failure 2.8 ± 0.63 <.0001 40%
FEV1, One-second forced expiratory volume; SD, standard deviation.
*Frequency of appearance in 1000 bootstrap analyses (see “Patients and Methods”).
†[FEV1]
2 squared transform.
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prohibits the detection of submucosal invasion and lym-
phatic spread. If ablation depth is adequate, complications
such as stricture and perforation increase.13 Furthermore,
ablation may be incomplete, and submerged Barrett epithe-
lium will be hidden from further surveillance.14-16
In theory, endoscopic mucosal resection is far more
appealing. The ability to inspect the resected specimen
allows determination of depth of invasion and detection of
lymphatic invasion. If pathologic review is favorable and
only high-grade dysplasia is found, esophagectomy may be
avoided. However, early experience with endoscopic
mucosal resection has been disappointing, with cancer
recurring in 17% of patients within an average follow-up of
12 months.17 After endoscopic mucosal resection, repopula-
tion of the esophageal mucosa with squamous epithelium
may be possible if gastroesophageal reflux is avoided. Acid
suppression may be difficult in patients with Barrett esoph-
agus.18-20 Surgical experience suggests that patients with
Barrett esophagus are more likely to have a short esophagus,
require complex surgical repairs, and have worse acid con-
trol than patients without Barrett esophagus.21,22
Resection for superficial esophageal carcinoma with low
morbidity and mortality is the challenge to surgeons. From
our experience, this requires meticulous patient selection
and preparation and a significant experience with
esophageal surgery. The patient with impaired respiratory
function should be carefully considered and perhaps denied
resection. Because these tumors are early stage, there is time
for pulmonary preparation, smoking cessation, and weight
loss. Impeccable surgical technique and prevention of post-
operative complications should minimize early operative
morbidity and deaths. It is the surgeon’s responsibility to
achieve the patient’s optimal condition. Unlike the majority
of patients with esophageal carcinoma, these patients have
the potential for long-term survival.
Although this study of a previously uncommon patient
population is seemingly large, in reality, it is small and not
randomized. However, the results strongly suggest that
endoscopic surveillance of patients with Barrett esophagus
and early intervention before the tumor invades deeply or
involves lymphatics provide the best long-term results.
Alternative therapy should be reserved for patients who are
not candidates for esophagectomy.
We thank Diane Baisden for data collection and follow-up and
Lucinda Mitchin for manuscript preparation.
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Appendix I. Trends Across the Experience
Changing prevalence of preoperative patient and disease character-
istics, operative technique, and postoperative complications across
the surgical experience were characterized by means of logistic
regression for binary variables and linear regression for continuous
variables. The calendar date of operation was expressed as a con-
tinuous interval since January 1, 1985. Logarithmic, inverse, and
power transformations were used to best characterize the informa-
tion. Trends found to be significant over time are presented in
Appendix Figure I. A nonsignificant (P = .3) trend was the increase
in prevalence of patients in endoscopic surveillance programs.
Appendix II. Variable Selection Criterion and Model
Validation
The P value for reduction of variables in the final model was lib-
eral because of the high possibility, given the small number of
deaths, that important variables related to survival would be
overlooked by too stringent a variable retention criterion (type II
error). The variable selection criteria exposed us to the risk of
model overdetermination, whereby risk factors cease to be gen-
eral common denominators and become identifiers of specific
individuals in the data set that have died (type I error).
Therefore, to balance these errors, all multivariable analyses
were supplemented by bootstrap resampling variable selec-
tion.7,23 For this, 1000 samples of the data set were drawn with
replacement, and an automated stepwise variable selection was
performed with an entry criterion of P = .12 and a retention cri-
terion of P = .1. For clusters of highly correlated variables, such
as all transforms of the same or similar variables (pulmonary
function tests, age, date of operation) or for closely related vari-
ables (surgical approach and location of esophageal anastomo-
sis, the variables identifying depth of tumor invasion), only 1
member of each cluster was allowed to be entered. By this strat-
egy, the frequency of occurrence of variables within each cate-
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Appendix Figure I. Time trends. A, Percent of patients undergoing a transhiatal esophagectomy. B, Percent of
patients whose anastomosis was in the neck. 
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gory yielded an accurate assessment of the likelihood that 1 vari-
able from that cluster should belong in the final model.
Appendix III. Adequacy of the Prognostic Model (Table 5)
To better understand the analyses, particularly with respect to the
high correlation among variables that can give rise to equivalent
but different models,24 we solved the prognostic equation for the
characteristics of each patient in the study.25,26 This produced an
individualized survival curve for each patient. The patients were
then stratified according to depth of tumor invasion, a variable not
in the risk factor model. The curves were averaged within each
stratum and compared with the Kaplan-Meier estimates.
Appendix Figure III indicates that the model is sufficient for
prognostication, despite not containing information directly about
depth of tumor invasion.
Appendix IV. Survival Compared with Matched US
Population
For informal comparison, a predicted population survival curve
was generated for each patient using (a) age at operation, (b) sex,
and (c) race. These curves were averaged within strata to yield a
comparative population life table.
Discussion
Dr Nasser K. Altorki (New York, NY). I congratulate Dr Rice and
his colleagues on bringing to us what is probably the largest series
of superficial adenocarcinoma in the United States, and probably
in Europe as well. 
You have reaffirmed 2 of our commonly held beliefs. One is that
an endoscopic diagnosis of high-grade dysplasia warrants an
esophagectomy. The incidence of cancer in your series is about
40%, much like the incidence reported by others. The second is
that patients who are enrolled in an endoscopic surveillance pro-
gram generally present with earlier stage disease and generally
have a better outcome, and I believe that to be true. 
I have 2 comments and 2 questions. In the manuscript as well as
in the presentation, there was almost a synonymous use of the
words high-grade dysplasia and cancer. I believe that once high-
grade dysplasia is confirmed in the resection specimen, it should
not be included in further analysis, particularly the survival analy-
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Appendix Figure I. Cont’d. Time trends.  C, Percent of patients requiring postoperative reintubation for respiratory
failure. D, Percent of patients experiencing an important surgical complication other than wound infection.
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sis of patients with invasive cancer. High-grade dysplasia is a
marker of associated invasive carcinoma, it is a preneoplastic
lesion, but, as you know, there is sufficient controversy about its
final outcome that I do not think it should be equated with cancer. 
You have concluded that an FEV1 of less than 2 L and respirato-
ry failure requiring reintubation both portend a poor outcome. I
understand that Dr Blackstone has applied quite a bit of statistical
firepower to this manuscript, and I am not going to challenge that.
However, I note that there were 12 patients who had an FEV1 of
less than 2 L in the whole group, probably about 10%, and 10
patients who required reintubation. I am hesitant to accept that rec-
ommendation given the small numbers involved, and I wonder
whether that conclusion can be tempered. 
I have 2 questions. You have stated that transhiatal esophagecto-
my is associated with a good outcome. We are all aware that stage
is the most important determinant of outcome, not particularly
where the surgeon places his incision. Would you care to elaborate,
Dr Rice, on the factors that influence the choice of your surgical
incision? Is it possible that there was some inherent selection bias
that affected the use of a transthoracic approach? 
The second question pertains to the survival figures presented. I
think the survival for stage T1a was 80%, and that is a reasonable
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Appendix Figure III. Kaplan-Meier estimates of tumor invasion as in Figure 3. The solid curves are predicted from
the prognostication model (Table 5). The inference from this depiction is that the model is sufficient for prognos-
tication, even though it does not contain information directly about depth of tumor invasion. Patients with high-
grade dysplasia are well represented by the smooth upper curve, as are patients with T1a tumors by the second
curve. After about 3 years, patients with T1b tumors fare worse than predicted, but the number of patients at that
point is so small that this additional variable did not provide significant information.
Appendix Figure IV. Survival within age groups compared with a matched US population. The dot-dash curve is
the matched survival among patients less than 55 years of age. The dash-dot-dot-dash curve is the population life
table for patients between the ages of 55 and 75 years. The lowest dash-dot-dot-dash curve is for the matched pop-
ulation more than 75 years of age.
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survival figure. Survival for T1b was about 50%. In our experi-
ence, that number should probably be in the 70%-plus range. Is it
possible that some of these patients were understaged primarily by
the use of a transhiatal or a less extensive lymph node dissection?
I am aware of your support for lymph node dissection. How do you
go about resecting lymph nodes for esophageal cancer? 
Dr Steve R. DeMeester (Los Angeles, Calif). Did you look at
the depth of tumor invasion independent of lymph node involve-
ment? One thing that we have come to realize is that intramucosal
cancers are rarely associated with lymph node metastases. Is that
the same in your experience? In other words, how many intramu-
cosal cancers had lymph node metastases? 
Next, is reintubation really a marker of sepsis, graft failure, or
graft leak and is that what you are looking at, or is the intubation
itself somehow important in the decrement in survival in these
patients? 
Last, getting back to the issue of whether intramucosal cancers
are associated with lymph node metastases or not, it has been our
experience that they are not associated with lymph node metastases.
Therefore, we can offer these patients an operation that we think is
an even better reconstruction, the vagus-sparing esophagectomy.
This procedure preserves the vagus nerves, strips the esophagus out
of the mediastinum, and is even less invasive than the transhiatal
approach. Have you had any thoughts in those directions? 
Dr Bruce J. Leavitt (Burlington, Vt). Knowing your results in
the high-risk category and based on your results in this report, have
you considered other forms of therapy for high-grade dysplasia of
the distal esophagus? 
Dr Reginald V. Lord (Los Angeles, Calif). What was the cause
of death in the patients with high-grade dysplasia? Specifically, did
any of them have cancer deaths? 
Dr Rice. I would like to thank Dr Altorki for his comments.
They will be considered in the revision of the manuscript. 
Your first question: What are the factors that determined whether
a patient would have a transhiatal esophagectomy? One factor is
my maturation as a surgeon. I became more comfortable over time
with transhiatal esophagectomy and I came to appreciate the
improvement in the patient’s recovery. My learning curve no doubt
affects the study. 
The question about survival: In the T1a group 5-year survival is
80%, and in the T1b group it is only 50%. It is interesting that of
the 13 cancer deaths, only 3 were due to local recurrence and 10
were from distant spread. This tells something about the efficacy
of the operation and the lack of an understaging effect that may
have existed because of the transhiatal approach. I would like to
point out that there are 3 lymphatic routes by which this tumor can
metastasize: It can spread along the submucosal lymphatics; in
10% of the patients it may spread directly into the thoracic duct;
and in the rest of the patients it will metastasize to regional lymph
nodes. This cancer can spread very early, and it can involve distant
sites before it spreads to regional lymph nodes. The rapid decrease
in survival with minimal increase in tumor invasion reflects the
possibility of distant spread without N1 disease. 
Dr DeMeester, 5% of our patients with intramucosal cancer had
regional lymph node metastases. This is the result of the lymphatic
anatomic peculiarity of the esophagus. There are lymphatics in the
muscularis mucosa and lamina propria. Twenty-five percent of our
patients with submucosal cancer had regional lymph node metas-
tases. This is less than your reported experience of 50% prevalence
of N1 disease in submucosal tumors. This may reflect our use of
transhiatal esophagectomy and your use of a rigorous lym-
phadenectomy, lymph node sampling versus lymphadenectomy. 
Reintubation, no doubt, reflects complications that result in res-
piratory failure, graft failure, aspiration pneumonia, adult respira-
tory distress syndrome, and other problems. Reintubation is a
marker. If a patient has to be reintubated, the cause of that problem
must be identified. 
This paper is interesting because it separates the disease from the
operation, because the survival is so good. If one can avoid a tho-
racotomy, the patient may do better. If an even less invasive oper-
ation than transhiatal esophagectomy can be done, the results may
even be better.
About other forms of treatments, the 2 forms of treatment that
you are suggesting are mucosal ablation and endoscopic mucos-
al resection. Mucosal ablation is a bad procedure in these
patients, because it ablates the findings we want to follow to
identify progression to cancer. It may also bury the columnar
epithelium under a pseudosquamous epithelium. Surveillance in
these patients will be inadequate. We have seen patients with
Barrett adenocarcinoma buried under this pseudosquamous
epithelium. Endoscopic mucosal resection is much more appeal-
ing. However, a recent report shows a 17% recurrence of cancer
within a 12-month follow-up in patients undergoing endoscopic
mucosal resection. In this group of patients with an excellent
prognosis with resection, we should look at ways to decrease the
morbidity of esophagectomy.
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